Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCSI Product of the Year

12 Oct 2007 08:46

PuriCore Plc12 October 2007 PuriCore's Sterilox Food Safety System Named FCSI Product of the Year Foodservice Consultants Society International Presents Award at Annual Conference MALVERN, PENNSYLVANIA, AND STAFFORD, UK - 12 October 2007 - PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens,received the Product of the Year award from the Foodservice Consultants SocietyInternational (FCSI) for its Sterilox Food Safety System. PuriCore's SteriloxFood Safety Division is a leading provider of environmentally friendly food-safesanitizers for use in the food retail, foodservice, and hospitality industries.FCSI presented the award for the Sterilox Food Safety System following a tallyof votes gathered from professional consultants at the FCSI Annual Conferencethis week in Atlanta, GA. FCSI is a prominent, globally recognized organization of nearly 1,000 membersworldwide who design foodservice installations and specify a broad range ofequipment ranging from commercial ovens and storage refrigerators to dishwashersand cleaning systems. At its annual conference, FCSI members vote on the mostinnovative product among ten finalists selected in the foodservice industry. Greg Bosch, CEO of PuriCore, said: "We are very honoured to win the prestigious FCSI Product of the Year award andconsider it a strong endorsement of our technology and its advancement in foodsafety. Already more than 1,500 leading food retailers and major hotel resortsuse the Sterilox Food Safety System as a highly effective way to enhance thesafety and freshness of perishable food products. This award is recognition fromwell-respected foodservice industry consultants that the Sterilox System shouldbe an integral part of our industry's food safety programs." About Sterilox Food Safety Systems Sterilox Food Safety Systems produce a natural food-safe sanitizer using onlysalt, water, and electricity. The Sterilox Food Safety Solution is used by morethan 1,500 leading retail supermarkets, foodservice, hospitality, andinstitutional properties to rinse fresh food products and sanitize food contactsurfaces to prevent cross contamination of infectious pathogens. The SteriloxSolution is highly effective at killing harmful pathogens and spoilage organismssuch as E.coli, Salmonella, Norovirus, Psuedomonas, yeast, and molds. When usedon fresh food, the Sterilox Solution reduces the risk of infectious pathogensand enhances the product shelf life. In addition, many of these operators usethe Sterilox BioSafety Solution as a wide-area disinfectant in housekeepinglocations to protect against and remediate viral and bacterial outbreaks bykilling harmful pathogens on contact. For more information, visit www.steriloxfresh.com. About PuriCore PuriCore (LSE: PURI) is a life sciences company focused on developing andcommercializing proprietary products that safely, effectively, and naturallykill contagious pathogens. PuriCore's technology provides a solution to a broadrange of markets that depend upon controlling contamination, including foodsafety, medical device disinfection, wound therapy, and hospitality. TheCompany's proprietary technology mimics the human body's production of thenatural antimicrobial hypochlorous acid, which is highly effective in killingbacteria, viruses, and fungal spores. Deploying hypochlorous acid solutions assoaks, sprays, mists, and in other forms, PuriCore's technology is designed tolimit the spread of infectious disease, including major public health threats ofM. tuberculosis, MRSA, E.coli, norovirus, avian influenza, HIV, polio virus,Helicobater pylori, and Legionella. PuriCore is headquartered in Malvern,Pennsylvania, with offices in Stafford, UK. To receive additional information on PuriCore, please visit our web site atwww.puricore.com, which does not form part of this press release. For further information please contact: PuriCore +1 484 321 2700 Keith Goldan Financial Dynamics +44 207 269 7169 Ben Brewerton This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 20197:00 amRNSCancellation of AIM Listing
25th Mar 20194:40 pmRNSSecond Price Monitoring Extn
25th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Mar 201911:12 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Mar 201910:31 amRNSForm 8.5 (EPT/RI) Earthport Plc
18th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
15th Mar 20192:35 pmRNSResult of General Meeting
15th Mar 201910:09 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
14th Mar 201911:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Mar 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
12th Mar 201911:53 amRNSForm 8.3 - Realm Therapeutics PLC
12th Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
8th Mar 201911:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Mar 201911:16 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Mar 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Mar 20199:32 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Mar 201911:41 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
1st Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
28th Feb 201911:14 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
27th Feb 20194:58 pmRNSForm 8.3 - Realm Therapeutics
27th Feb 20194:41 pmRNSSecond Price Monitoring Extn
27th Feb 20194:36 pmRNSPrice Monitoring Extension
27th Feb 201911:01 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
26th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
25th Feb 201910:08 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
22nd Feb 201911:36 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
22nd Feb 201910:02 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Feb 20194:34 pmRNSForm 8.3 - Realm Therapeutics plc
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 201912:36 pmGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics Plc
21st Feb 20199:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Feb 201910:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Feb 20192:05 pmRNSSecond Price Monitoring Extn
19th Feb 20192:00 pmRNSPrice Monitoring Extension
19th Feb 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Feb 20199:25 amRNSForm 8.5 (EPT/RI)Realm Therapeutics
18th Feb 20199:05 amRNSSecond Price Monitoring Extn
18th Feb 20199:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSBlock listing Interim Review
18th Feb 20197:00 amRNSUpdate on Strategic Review Re-release
15th Feb 20196:20 pmRNSUpdate on Strategic Review
15th Feb 20199:22 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Feb 20199:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Feb 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Feb 20199:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Feb 201911:23 amRNSForm 8.5 (EPT/RI) Realm Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.